Formulation of sustained Release Tablets of piperazine and piperidine agonists and antagonists of 5-ht1a receptor have improved intestinal dissolution

摘要

The present Invention relates to formulations of sustained Release Tablets of piperazine and piperidine Compounds, which may be useful in the treatment of disorders of the central nervous system; processes for their preparation, and Methods of their use.